Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

The Chimeric Self

J. Lee Nelson, MD, and Anne Stevens, MD, PhD  |  Issue: February 2007  |  February 1, 2007

Dr. Nelson is professor of immunogenetics in the clinical research division of Fred Hutchinson Cancer Research Center and professor of medicine at the University of Washington in Seattle. Dr. Stevens is assistant professor of pediatrics in the division of immunology and rheumatology at the University of Washington in Seattle and in the department of immunology and rheumatology at Children’s Hospital and Regional Medical Center.

References

  1. Tuffrey M, Bishun NP, Barnes RD. Porosity of the mouse placenta to maternal cells. Nature 1969;221:1029-1030.
  2. Lo YMD, Lau TK, Chan LYS, Leung TN, Chang AMZ. Quantitative analysis of the bi-directional fetomaternal transfer of nucleated cells and plasma DNA. Clin Chem. 2000;46:1301-1309.
  3. Hench PS. The ameliorating effect of pregnancy on chronic atrophic (infectious rheumatoid) arthritis, fibrositis, and intermittent hydrarthrosis. Mayo Clin Proc. 1938;13:161-167.
  4. Nelson JL, Hughes KA, Smith AG, et al. Maternal-fetal disparity in HLA class II alloantigens and the pregnancy-induced amelioration of rheumatoid arthritis. N Engl J Med. 1993;329:466-471.
  5. Yan Z, Lambert NC, Guthrie KA, et al. Male microchimerism in women without sons: Quantitative assessment and correlation with pregnancy history. Am J Med. 2005;118:899-906.
  6. Adams K, Yan Z, Stevens AM, Nelson JL. The changing maternal “self” hypothesis: A mechanism for maternal tolerance of the fetus. Placenta. 2006; epub advance of print August 23: doi:10.1016/j.placenta.2006.07.003.
  7. Bianchi DW, Zickwolf GK, Weil GJ, Sylvester S, DeMaria MA. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci. 1996;93:705-708.
  8. Adams KA, Nelson JL. Microchimerism: An investigative frontier in autoimmunity and transplantation. JAMA. 2004;291:1127-1131.
  9. Maloney S, Smith AG, Furst DE, et al. Microchimerism of maternal origin persists into adult life. J Clin Invest. 1999,4:41-47.
  10. Nelson JL. Maternal-fetal immunology and autoimmune disease. Is some autoimmune disease auto-alloimmune or allo-autoimmune? Arthritis Rheum. 1996;39:191-194.
  11. Nelson JL, Furst DE, Maloney S, et al. Microchimerism and HLA-compatible relationships of pregnancy in SSc. Lancet. 1998;351:559-562.
  12. Lambert NC, Erickson TD, Zhen Y, et al. Quantification of maternal microchimerism by HLA specific real-time PCR. Studies of healthy women and women with scleroderma. Arthritis Rheum. 2004;50:906-914.
  13. Loubiere LS, Lambert NC, Flinn L, et al. Maternal microchimerism in healthy adults in lymphocytes, monocyte/macrophages, and NK cells. Lab Invest. 2006; advance online September 11: doi:10.1038/labinvest. 3700471.
  14. Reed AM, Picornell YJ, Harwood A, Kredich DW. Chimerism in children with juvenile dermatomyositis. Lancet. 2000;356:2156-2157.
  15. Artlett CM, Ramos R, Jiminez SA, et al. Chimeric cells of maternal origin in juvenile idiopathic inflammatory myopathies. Lancet. 2000;356:2155-2156.
  16. Reed AM, McNallan K, Wettstein P, Vehe R, Ober C. Does HLA-dependent chimerism underlie the pathogenesis of juvenile dermatomyositits? J Immunol. 2004;172:5041-5046.
  17. Stevens AM, Hermes H, Rutledge R, Buyon J, Nelson JL. Maternal microchimerism has myocardial tissue-specific phenotype in neonatal lupus congenital heart block. Lancet. 2003;362:1617-1623.
  18. Khosrotehrani K, Johnson KL, Cha DH, Salomon RN, Bianchi DW. Transfer of fetal cells with multilineage potential to maternal tissue. JAMA. 2004;292:75-80.
  19. Stevens AM, Mullarkey ME, Pang JM, et al. Liver biopsies from human females contain male hepatocytes in the absence of transplantation. Lab Invest. 2004;84:1603-1609.
  20. Portanova JP, Kotzin BL. Lupus-like autoimmunity in murine graft-versus-host disease. Concepts Immunopathol. 1988;6:119-140.
  21. Stevens AM, Tsao B, Hahn B, et al. Maternal HLA class II compatibility in men with systemic lupus erythematosus. Arthritis Rheum. 2005;52:2768-2773.
  22. Stevens AM. Microchimeric cells in systemic lupus erythematosus: Targets or innocent bystanders? Lupus. 2006;15:820-826
  23. Hovinga IC, Koopmans M, Baelde HJ, et al. Chimerism occurs twice as often in lupus nephritis as in normal kidneys. Arthritis Rheum. 2006;54:2944-2950.

Page: 1 2 3 4 5 6 7 | Single Page
Share: 

Filed under:ConditionsResearch Rheum Tagged with:microchimerismpregnancyResearchRheumatic Disease

Related Articles
    How HLA-B27 Research Landmarks, Advances Relate to Ankylosing Spondylitis Pathogenesis

    How HLA-B27 Research Landmarks, Advances Relate to Ankylosing Spondylitis Pathogenesis

    July 13, 2016

    The mechanistic link between human leukocyte antigen B27 (HLA-B27) and ankylosing spondylitis (AS) is one of the great enigmas in rheumatology. The introduction of biological therapies that target tumor necrosis factor (TNF) or the interleukin (IL) 23/IL-17A axis has had a major impact on the quality of life for many patients with AS, and one…

    Capillaroscopy a Safe and Direct Method for SSc Diagnosis

    June 13, 2011

    Seeing vessels clearly can help with discovery and timely treatment

    Scleroderma & ILD: Practical Tips on the Diagnosis & Management of Systemic Sclerosis-Associated Interstitial Lung Disease

    June 15, 2022

    No one-size-fits-all approach exists for the care and treatment of patients with systemic sclerosis (SSc) and SSc with pulmonary involvement. Here, experts discuss some best clinical practices for these patients.

    Progress Continues in Systemic Sclerosis

    March 1, 2010

    Advances in genetics and potential therapies shed new light on the disease

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences